| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.72B | +0.7% |
| Cost of Revenue | $2.81B | +3.3% |
| Gross Profit | $914.0M | -6.5% |
| R&D Expense | $48.0M | +6.7% |
| SG&A Expense | $382.0M | -11.0% |
| Pre-tax Income | $393.0M | -12.9% |
| Income Tax | $92.0M | -7.1% |
| Net Income | $301.0M | -14.5% |
| EPS (Basic) | $1.43 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $147.0M | +7.3% |
| Accounts Receivable | $355.0M | +5.3% |
| Inventory | $584.0M | +3.0% |
| Current Assets | $1.12B | +1.4% |
| Total Assets | $4.94B | +1.3% |
| Current Liabilities | $577.0M | +7.1% |
| Long-term Debt | $1.59B | -5.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $477.0M | -2.5% |
| Capital Expenditures | $161.0M | +34.2% |
| Investing Cash Flow | -$161.0M | -34.2% |
| Financing Cash Flow | -$306.0M | +11.6% |
| Free Cash Flow | $316.0M | -14.4% |
| -14.9% |
| EPS (Diluted) | $1.43 | -14.4% |
| Total Liabilities |
| $2.68B |
| -1.8% |
| Stockholders' Equity | $2.25B | +5.2% |